Problem Statement: Collecting race and ethnicity data can provide health care organizations with useful information about their patients, including whether any racial and ethnic patient populations are experiencing disparities in their health and health care. How might we reconcile the importance of racial/ethnic data collection with the variable understanding and application of race to treatment guidelines? Should we continue to collect self-identified race and ethnicity data from our patients?

Problem Statement: Clinician expertise and familiarity with the history, complexity and validity of race-based guidelines is variable.  How do we provide education and support for clinicians as they begin to grapple with and apply new knowledge?

1. Provide training or education to providers on the use of race in medicine; on-going series of debates and conversations needed for professional development

2. Define key learning objectives for our clinicians including:

Problem Statement: Physicians lack consensus on the meaning of race and if racial and ethnic categories reflect underlying population genetics and are clinically useful; or if any small benefit in the use of race is outweighed by harms that arise due to the history of racism in medicine.  As practicing clinicians, how should we interpret and act on race-based guidelines?

Suggested Strategies:

How can research related to genetics include appropriate consideration of the nuanced relationship between ancestry and race/ethnicity in both methods and interpretation/dissemination?

Next steps for next 12 months:

What are best practices for interpreting differences in outcomes by race/ethnicity, with attention to the social construction of race and the role of racism in the patterning of health?

Next steps for next 12 months:

How should race/ethnicity and racism be collected and analyzed in clinical and translational research, with an eye to both the impact on social narratives related to race and the impact on clinic care?

Next steps for next 12 months:

What are best practices for ensuring that diverse participants are included in clinical and translational research? How can researchers ensure that an emphasis on this diversity is not interpreted as implying a genetic definition of race?

Next steps for next 12 months: